
Aegis Ventures is a next-generation startup studio that partners with entrepreneurs and industry leaders to originate, launch, and scale transformative companies, with a focus on artificial intelligence. The Aegis platform brings together market-shaping ideas, permanent growth capital, and ambitious individuals who are driven to solve major societal problems. Our companies use technology to transform healthcare by dramatically improving quality, access, and cost. Aegis creates new companies with substantial input from our Digital Consortium of a dozen leading health systems and other ecosystem partners. We have launched 6 innovative companies to date and are just getting started.
Optain is a revolutionary healthcare company that uses groundbreaking software and hardware technology to rethink care. We use the eye as a window to the body to improve the way we detect and manage eye and systemic conditions. Optain is committed to expanding and improving care through the introduction of AI and machine learning technology frontline care settings at an accessible price. This not only promotes greater access to care, but promises to reduce the strains of overburdened healthcare systems.
Originally founded in Australia in 2019, Optain seeks to commercialize the inventions of Professor Mingguang He, a preeminent clinician-scientist and scholar in the field of ophthalmology. Optain has achieved regulatory approval and commercial adoption of its product suite in global markets, including Australia, Europe, and more.
In 2025, Optain received US FDA clearance for its Resolve retinal camera. Optain also recently closed a Series A funding round led by Insight Partners with participation from seven leading U.S. health system investors, including Memorial Hermann Health System, Northwell Health, Novant Health, The Ohio State University Wexner Medical Center, and UPMC. These systems collectively deliver care to 28 million patients across 25 states and have begun deploying Optain's platform across their networks, rapidly accelerating the company's footprint and expanding screening access nationwide. Optain also acquired EyePACS, a teleophthalmology platform with a 15-year history and an established network of licensed optometrists and ophthalmologists who read retinal images for diabetic retinopathy screening.
As the Clinical Operations Manager, you will own the operations of Optain's provider network -- the optometrists and ophthalmologists who read retinal images for health systems, clinics, and community health centers across the United States. The network has run for 15 years on the judgment and relationships of a small number of people. Your job is to turn that into documented policy, a measurable quality program, a capacity model that runs ahead of demand, and a governance rhythm in alignment with Optain’s Medical Director. You will report to the VP of Operations and work day to day with Optain's Medical Director. This is a non-clinical role for someone who has managed a network of contracted clinicians before, writes policy that physicians sign, and knows the difference between running a process and building one that doesn't need you.
Optain is at an inflection point. We have FDA clearance, a growing camera footprint, and a commercial pipeline that is moving fast. Behind every screening exam is a licensed grader reading the images through our EyePACS platform, and the operational infrastructure around that network is being built in real time. This role sits at the center of that work.
This is a remote, US-based position.
Why Optain? Make a real difference: Your work will help solve difficult problems as you collaborate with world-class experts from healthcare provider networks, academia, and industry. Join Optain in transforming healthcare with AI!
Aegis Ventures is a proud Equal Opportunity Employer — we recruit, train, compensate and promote our team members based on qualifications. We encourage you to apply regardless of your race, religion, national origin, sex, gender identity, sexual orientation, disability, age, veteran status, or any other applicable legally protected characteristics.

Aegis Ventures is a NYC-based venture studio that partners with entrepreneurs and health systems to launch and scale meaningful healthtech startups that drive healthcare forward. The Aegis platform combines deep insights, aligned capital, and proprietary access to customers to substantially increase the velocity and success rate of the new companies we build.